Trial · NCT00814177
Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients
NCT00814177, Phase 2, Completed, Hamilton Health Sciences Corporation; results first posted 2009-11-25
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients. Trials, record NCT00814177. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00814177
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients
- NCT number
- NCT00814177
- Status
- Completed
- Phases
- Phase 2
- Enrollment
- 160 participants, actual
- Lead sponsor
- Hamilton Health Sciences Corporation
- Conditions
- Atrial Fibrillation, Venous Thromboembolism, Ischemic Stroke, Myocardial Infarction
- Interventions
- warfarin, warfarin
- First posted
- 2008-12-24
- Last updated
- 2012-08-01
- Results first posted
- 2009-11-25
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Patients With Prothrombin Time Results Within the Therapeutic Range After 2 Weeks | 2 weeks | The number of patients with "follow-up INRs" within the therapeutic range was compared for patients with a single dose skipped/reduced/added versus patients with no change of dose. |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Patients With Prothrombin Time Results Within the Therapeutic Range After 2 Weeks | 2 weeks | participants | NUMBER |
Source ClinicalTrials.gov
Results by group2
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Patients With Prothrombin Time Results Within the Therapeutic Range After 2 Weeks | No Change | 48 | participants | ||
| Number of Patients With Prothrombin Time Results Within the Therapeutic Range After 2 Weeks | Change | 45 | participants |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | No Change | 80 | |
| Overall Study | STARTED | Change | 80 | |
| Overall Study | COMPLETED | No Change | 80 | |
| Overall Study | COMPLETED | Change | 80 | |
| Overall Study | NOT COMPLETED | No Change | 0 | |
| Overall Study | NOT COMPLETED | Change | 0 |
Source ClinicalTrials.gov
Adverse events6
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | ventricular tachycardia | Cardiac disorders | No Change | 1 | 80 | 1 |
| other | ventricular tachycardia | Cardiac disorders | Change | 0 | 80 | 0 |
| other | food poisoning | Gastrointestinal disorders | No Change | 1 | 80 | 1 |
| other | food poisoning | Gastrointestinal disorders | Change | 0 | 80 | 0 |
| other | bleeding from penis | Reproductive system and breast disorders | No Change | 0 | 80 | 0 |
| other | bleeding from penis | Reproductive system and breast disorders | Change | 1 | 80 | 1 |
Source ClinicalTrials.gov
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | No Change | ||
| Total, all-cause mortality | Change | ||
| Total, other adverse events | No Change | 2 | 80 |
| Total, other adverse events | Change | 1 | 80 |
| Total, serious adverse events | No Change | 0 | 80 |
| Total, serious adverse events | Change | 0 | 80 |
Source ClinicalTrials.gov
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 19640572 | RESULT |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons2
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| No Change vs Change: Number of Patients With Prothrombin Time Results Within the Therapeutic Range After 2 Weeks | Trial comparisons |
| No Change vs Change: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00814177
GET https://conductscience.org/api/trials/v1/NCT00814177/registered